论文部分内容阅读
美国约有0.1～0.5%的人为乙型肝炎病毒(HBV)携带者,而在南朝鲜的美国士兵的HBV年感染率为0.6～6%,因此,有必要对所有准备派往南朝鲜的美国士兵接种乙型肝炎疫苗。但常规的肌肉接种途径,耗资较大,故建议实行皮内接种方案。接种方案为:上臂外侧皮内接种3剂血源性乙型肝炎疫苗,每次接种的时间分别为0、30～60和60～180天,每剂2μg(0.1ml)。所有血清都用Abbott试剂检测抗-HBs和抗-HBc,必要时还可检测抗-HBcIgM和HBcAg。结果按以下要求判断;样本比率单位(SRU)≥2.1为血清阳转,≥10为达到保护性抗体
In the United States, about 0.1% to 0.5% of people are carriers of hepatitis B virus, while the annual rate of HBV infection among U.S. soldiers living in South Korea is 0.6% to 6%. Therefore, it is necessary that all those who are prepared to send to South Korea Soldiers inoculated with hepatitis B vaccine. However, the conventional route of muscle inoculation, cost more, it is recommended to implement intradermal vaccination program. Inoculation programs were: intradermal inoculation of 3 doses of blood-borne hepatitis B vaccine in the upper arm, each vaccination for 0, 30-60 and 60-180 days, 2 μg (0.1 ml) per dose. Antibodies against HBs and anti-HBc were detected in all sera with anti-HBcIgM and HBcAg if necessary. The results were judged according to the following requirements: the sample ratio unit (SRU) ≥2.1 was seroconverted, ≥10 was the protective antibody